5-53603451-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_002495.4(NDUFS4):āc.99-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,612,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Consequence
NM_002495.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFS4 | NM_002495.4 | c.99-1G>A | splice_acceptor_variant, intron_variant | ENST00000296684.10 | NP_002486.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151374Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251408Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135886
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1460990Hom.: 0 Cov.: 30 AF XY: 0.0000261 AC XY: 19AN XY: 726888
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151374Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73844
ClinVar
Submissions by phenotype
Mitochondrial complex I deficiency, nuclear type 1 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jun 07, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2003 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 21, 2023 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 24, 2024 | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 16213125, 10944442, 22326555, 19107570, 20818383, 12616398) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2023 | This sequence change affects an acceptor splice site in intron 1 of the NDUFS4 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NDUFS4 are known to be pathogenic (PMID: 10944442, 16213125). This variant is present in population databases (rs376281345, gnomAD 0.003%). Disruption of this splice site has been observed in individual(s) with mitochondrial complex I deficiency (PMID: 12616398, 20818383). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as IVS1nt āĆƬ1 (GāĆĆA). ClinVar contains an entry for this variant (Variation ID: 496165). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Leigh syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 12, 2016 | Variant summary: The c.99-1G>A variant affects a conserved splice site nucleotide. One in-silico tool predicts damaging outcome for this variant. 5/5 programs in Alamut predict that this variant affects normal splicing, which is confirmed by RT-PCR in patients carrying this variant, showing the variant causes the complete skipping of exon 2. This variant is found in 2/120974 control chromosomes at a frequency of 0.0000165, which does not significantly exceed maximal expected frequency of a pathogenic allele (0.00125). In addition, reputable database classified this variant as pathogenic. Taken together, this variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at